Novel approaches for the treatment of ALL in adults were discussed. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Valera Duration: 30 mins

We discussed about copper deficiency in myelodysplastic syndrome (MDS) patients Presenter: Prof Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Valera Duration: 40 mins

The combination of venetoclax and gilteritinib is a highly active and tolerable oral combination regimen that potentially improves response frequency and depth over existing standards in a high-risk, mutation-defined group of patients with AML. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr...

We discussed about preliminary analysis of the prospective, multicenter, phase III NEUTRODIET trial, which is studying the effects of diet on infection rates during neutropenia in patients undergoing autologous (auto)- or allogeneic (allo)‑HSCT. Data presented at EHA2022 Presenter: Prof. Spyridonidis Participants: Dr. Liga,...

The new molecular m-IPSS is presented Presenter Prof. Spyridonidis Participants Dr. Liga, Dr Tsokanas, Dr. Valera  Duration: 30 mins 

Integrating Morphological, Clinical, and Genomic Data 2022 ELN International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data 5th WHO Presenter: Prof. Spyridonidis Participants: Dr. Liga, Dr Tsokanas, Dr. Valera  Duration: 30 mins 

Efficacy and safety of 10-day DEC followed by allografting to IC followed by allografting in older fit AML patients was discussed. Presenter: Prof. Spyridonidis Participants: Dr. Tsokanas, Dr. Liga, Dr. Valera Duration: 30 mins

2022 European Leukemia Net (ELN) Recommendations for AML were discussed. Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas, Dr Valera Duration: 45 mins

Randomized study showing better pfs in mm patients treated with triple therapy and upfront autologous hct vs no hct Presenter: Prof. Spyridonidis Participants: Dr. Liga, Dr Tsokanas, Dr. Valera https://www.nejm.org/doi/full/10.1056/NEJMoa2204925  

We presented the new molecular International Prognostic Scoring System of MDS  Presenter: Prof. Spyridonidis Participants: Dr.Liga, Dr. Tsokanas, Dr. Valera Dr. Verigou Dr. Lyssandrou

Keypoints t-AML, sAML, AML-MRC can be nowadays clinically, morphologically and genetically (cytogenetics, somatic mut) identified In these pts (most > 60 y of age) CPX-351 enables efficient and safe delivery of intensive chemotherapy Consolidation with HCT in these pts is curative with real...

4o Eκπαιδευτικό Σεμινάριο στη Μεταμόσχευση Μυελού των Οστών: Πως ενσωματώνονται οι θεραπείες στόχευσης, η ανοσοθεραπεία και οι κυτταρικές θεραπείες στον σύγχρονο θεραπευτικό αλγόριθμο. Επισυνάπτεται η ομιλία της Λίγκα Μαρία Ιατρού Αιματολόγου της ΜΜΜΟ ΠΓΝΠ με τίτλο "Επιλογή δότη στην απλοταυτόσημη μεταμόσχευση" Παρουσιαστής:...

4o Eκπαιδευτικό Σεμινάριο στη Μεταμόσχευση Μυελού των Οστών: Πως ενσωματώνονται οι θεραπείες στόχευσης, η ανοσοθεραπεία και οι κυτταρικές θεραπείες στον σύγχρονο θεραπευτικό αλγόριθμο. Επισυνάπτεται η ομιλία του Τσοκάνα Δημητρίου, Ιατρού Αιματολόγου της ΜΜΜΟ ΠΓΝΠ με τίτλο "Επαναπροσδιορίζοντας τις θεραπείες επιλογής, βελτιώνοντας...

We discussed the new findings of AML MRC, secondary AML and the therapeutic option with Vyxeos Presenter Spyridonidis Particpants: Tsokanas, Liga, Valera

Presentation of a consensus document from the European LeukemiaNet MRD Working Party | Blood | American Society of Hematology Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas Duration: 40 mins

Presenter: Gakis Georgios, 4th year undergraduate MD student Participants: Prof. Spyridonidis, Dr Liga, Dr Tsokanas Duration: 30 mins

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas, A. Christopoulou, E. Sagiadinou, V. Zacharioudaki, E.Triantafyllou Duration: 40 mins Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022

Presenter: Prof. Spyridonidis Participants: Dr Liga, Dr Tsokanas Duration: 30mins We discussed a case of PCNSL in an HIV patient and reviewed the literaure about the pathogenic role of EBV. In such immunocomprisised patients, the detection of EBV transcript in all of the...